ASCO23

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

ASCO23
May 29, 2025, 09:11 | Blog
Aakash Desai Launches First Podcast Episode at ASCO25 with Oncology News Central
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 7, 2024, 13:38 | Blog
Anand Patel: Imetelstat approved for lower-risk MDS with anemia
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago,…
Feb 14, 2024, 18:02 | Blog
Mark Lewis: Dr. Andrew Ko’s observation at ASCO23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX!
Mark Lewis shared on X: “Seems relevant to resurface Dr. Andrew Ko’s observation at ASCO23…
Dec 17, 2023, 03:29 | Blog
Advancing the Battle Against Platinum-Resistant Ovarian Cancer: Promising Strategies from 2023 ASCO & ESMO Meetings
The 2023 ASCO and ESMO meetings provided novel insights for treating platinum-resistant ovarian cancer, a…
Aug 16, 2023, 19:31 | Societies
Mark your calendars for our FIRST live lung cancer journal club discussing updated results from the ADAURA trial - LungCancerRx
Quoting a post from Twitter user "LungCancerRx": "Exciting News! Mark your calendars for our FIRST…
Jul 18, 2023, 20:06 | Blog
I argue that crossover should not be “allowed”- they should either be “mandated” or “prohibited” - Bishal Gyawali
Hot off the press in NatureRevClinOncol! Using examples from trials presented at ASCO23, in this…
Jun 22, 2023, 19:15 | Positive
We are at a pivotal time for treatment innovations in hematological malignancies - Anas Younes
We are at a pivotal time for treatment innovations in hematological malignancies, and our data…
Jun 19, 2023, 18:18 | Career
I rejoined (best!) ASCO International Affairs Committee in capacity as Chair-Elect - Herbert Loong
As ASCO23 ends & we eagerly look forward to ASCO24, I am pleased to announce…
Jun 12, 2023, 04:02 | Blog
I closed my ASCO23 with 65507+ steps- Abdelali (Ali) MAJDI
I closed my ASCO23 with 65507+ steps Every step opened new opportunities to learn, connect, and…
Jun 10, 2023, 11:59 | Blog
An Unforgettable Journey: Reflections on ASCO23 Annual Meeting - Matteo Lambertini
Time to go home after an exciting #ASCO23 annual meeting…I have to admit that when I entered…
Jun 10, 2023, 02:53 | Blog
Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino
Consistent with the PACE trial, the PALMIRA randomized phase 2 trial showed no benefit in…
Jun 8, 2023, 18:38 | Blog
I'm pleased to share three papers in Cancer Discovery- Elizabeth McKenna
I'm pleased to share three papers in #CancerDiscovery that were published simultaneously with posters/presentations at #ASCO23: From the…
Jun 7, 2023, 18:50 | Opinion
Advancements in Cancer Drug Development: Sanofi’s Commitment to Impactful Therapies and Data Sharing at ASCO23
In the past two decades, we have witnessed remarkable advancements in cancer treatment, with groundbreaking…
Jun 4, 2023, 17:42 | Opinion
Putting Patients First: The Crucial Role of Patient Partnership in Cancer Care and Research
"Partnering With Patients: The Cornerstone of Cancer Care and Research" - Reflecting on the ASCO…
Jun 4, 2023, 17:11 | Blog
Reflecting on a Significant Life Milestone: Departing MD Anderson Cancer Center after 15 Years of Dedication
Today marks a significant milestone in my life as I bid farewell to MD Anderson…
All: 15 Posts: 1 - 100
Special Coverage